Can fasting help to fight against cancer?

Pro Search

3 steps completed
Answer
Fasting has been suggested to play a role in cancer treatment by creating conditions that limit cancer cells' adaptability, survival, and growth. Emerging evidence indicates that intermittent fasting might help prevent and treat cancer by boosting the efficacy and tolerance of anticancer drugs and improving cancer patients' quality of life through various biological mechanisms caused by intermittent fasting5. Some studies have shown that fasting can reduce blood glucose levels, making it harder for cancers to grow, as cancer cells feed on glucose at a much higher level than normal cells do4. However, it is important to note that clinical trials do not yet provide sufficient data to support the general use of intermittent fasting in clinical practice3. Moreover, fasting may not be appropriate for malnourished individuals, those with cancer cachexia (a continuing loss of skeletal muscle mass), or people with chronic diseases4. Fasting is also not recommended for people with a history of eating disorders or those with wounds that need adequate nutrition to heal4. In summary, while there is some evidence suggesting that fasting could potentially help in the fight against cancer, more research is needed to establish its effectiveness and safety in cancer patients. It is essential for cancer patients to consult their oncologist or care team before considering fasting as part of their treatment plan.
what types of cancer have been studied in relation to fasting

Pro Search

4 steps completed
Answer
Fasting, particularly intermittent fasting and fasting-mimicking diets (FMDs), has been studied in relation to various types of cancer, including breast cancer, prostate cancer, lung cancer, colon cancer, and pancreatic cancer. Breast cancer has been a significant focus of fasting-related research. For instance, a study found that an increase in fasting time at night was associated with lower HbA1c levels, which could potentially reduce the risk of breast cancer recurrence4. Another study suggested that fasting for 13 hours a day may reduce breast cancer recurrence and death from the disease5. Prostate cancer has also been studied in relation to fasting. A study on prostate cancer highlighted potential issues of fasting that require further investigation, such as metabolic complications like malnutrition and sarcopenic obesity4. An ongoing clinical trial is investigating the effects of intermittent fasting using a fasting-mimicking diet to improve prostate cancer control and metabolic outcomes6. Research on lung cancer, colon cancer, and pancreatic cancer in relation to fasting is less extensive. However, a study mentioned that fasting seems to treat a variety of cancers, including lung cancer4. It's important to note that while fasting has been shown to have potential benefits in cancer treatment, such as increasing the effectiveness of cancer therapies and reducing their side effects12, more research is needed to fully understand these effects and to identify which patients may benefit most from fasting strategies45. Furthermore, fasting may not be appropriate for all patients, particularly those who are malnourished or have certain chronic diseases5. Therefore, any decision to fast should be made in consultation with a healthcare provider.
what is the recommended duration of fasting for cancer patients

Pro Search

3 steps completed
Answer
The recommended duration of fasting for cancer patients varies depending on the specific fasting strategy and the individual's health condition. Preliminary clinical data suggest that a fast of at least 48 hours may be required to achieve clinically meaningful effects in oncology, such as preventing chemotherapy-induced DNA damage to healthy tissues and helping to maintain patient quality of life during chemotherapy2. However, most patients may find it challenging to complete water fasting, and the potential risks of extended calorie and micronutrient deficiency associated with it are difficult to justify2. In some studies, cancer patients have voluntarily fasted for 48 to 140 hours before chemotherapy and 5 to 56 hours after chemotherapy7. It is important to note that fasting may not be appropriate for all patients, particularly those who are malnourished or have certain chronic diseases1. Therefore, any decision to fast should be made in consultation with a healthcare provider. In general, more research is needed to determine the optimal fasting duration for cancer patients. It is crucial for cancer patients to consult their oncologist or care team before considering fasting as part of their treatment plan.
Related
what are the potential benefits of fasting for cancer patients
what are the different types of fasting that have been studied in relation to cancer
what are the potential risks of fasting for cancer patients